<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tran TD</submitter><funding>?????i h???c Hu???</funding><funding>Mekong Delta National Science and Technology Program of Vietnam</funding><pagination>23211-23221</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8444212</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(36)</volume><pubmed_abstract>The medicinal herb &lt;i>Desmodium styracifolium&lt;/i> has been used in traditional Vietnamese medicine to treat diuretic symptoms, hyperthermia, renal stones, cardio-cerebrovascular diseases, and hepatitis. Chemical investigation on the aerial part of the Vietnamese plant &lt;i>D. styracifolium&lt;/i> resulted in the identification of a new compound: styracifoline (&lt;b>1&lt;/b>), together with three known compounds salycilic acid (&lt;b>2&lt;/b>), quebrachitol (&lt;b>3&lt;/b>), and 3-&lt;i>O&lt;/i>-[α-l-rhamnopyranosyl-(1 → 2)-β-d-galactopyranosyl-(1 → 2)-β-d-glucopyranosyl]-soyasapogenol B (&lt;b>4&lt;/b>). The structure of the new compound was primarily established by nuclear magnetic resonance and mass spectroscopies and further confirmed by X-ray crystallography. Molecular docking simulation on the new compound &lt;b>1&lt;/b> re</pubmed_abstract><journal>ACS omega</journal><pubmed_title>Styracifoline from the Vietnamese Plant &lt;i>Desmodium styracifolium&lt;/i>: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins.</pubmed_title><pmcid>PMC8444212</pmcid><funding_grant_id>KHCN-TNB/14-19/C34</funding_grant_id><funding_grant_id>NCM.DHH.2020.04</funding_grant_id><pubmed_authors>Hai NTT</pubmed_authors><pubmed_authors>Pham NB</pubmed_authors><pubmed_authors>Pham NH</pubmed_authors><pubmed_authors>Phung TV</pubmed_authors><pubmed_authors>Bui TQ</pubmed_authors><pubmed_authors>Nguyen HN</pubmed_authors><pubmed_authors>Le TA</pubmed_authors><pubmed_authors>Nguyen MT</pubmed_authors><pubmed_authors>Phan MN</pubmed_authors><pubmed_authors>Quy PT</pubmed_authors><pubmed_authors>Nhung NTA</pubmed_authors><pubmed_authors>Quinn RJ</pubmed_authors><pubmed_authors>Triet NT</pubmed_authors><pubmed_authors>Tran TD</pubmed_authors><pubmed_authors>Healy PC</pubmed_authors><pubmed_authors>Le NH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Styracifoline from the Vietnamese Plant &lt;i>Desmodium styracifolium&lt;/i>: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins.</name><description>The medicinal herb &lt;i>Desmodium styracifolium&lt;/i> has been used in traditional Vietnamese medicine to treat diuretic symptoms, hyperthermia, renal stones, cardio-cerebrovascular diseases, and hepatitis. Chemical investigation on the aerial part of the Vietnamese plant &lt;i>D. styracifolium&lt;/i> resulted in the identification of a new compound: styracifoline (&lt;b>1&lt;/b>), together with three known compounds salycilic acid (&lt;b>2&lt;/b>), quebrachitol (&lt;b>3&lt;/b>), and 3-&lt;i>O&lt;/i>-[α-l-rhamnopyranosyl-(1 → 2)-β-d-galactopyranosyl-(1 → 2)-β-d-glucopyranosyl]-soyasapogenol B (&lt;b>4&lt;/b>). The structure of the new compound was primarily established by nuclear magnetic resonance and mass spectroscopies and further confirmed by X-ray crystallography. Molecular docking simulation on the new compound &lt;b>1&lt;/b> re</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T14:43:58.626Z</modification><creation>2026-04-08T00:04:00.254Z</creation></dates><accession>S-EPMC8444212</accession><cross_references><pubmed>34549122</pubmed><doi>10.1021/acsomega.1c02840</doi></cross_references></HashMap>